Looking for a District of Columbia Ziagen lawyer? Get in touch with one of our District of Columbia Ziagen lawyers now.

Ziagen - News Articles

Kansas City infoZine News - Duck-billed Platypus Genome Sequence Published - USA
May 13, 2008
Kansas City infoZine, MO -
The first analysis of the genome sequence of the duck-billed platypus was published recently by an international team of scientists, revealing clues about how genomes were organized during the early evolution of mammals. Washington, D.C. - infoZine ...
Getting up close and personal - Science - Specials - smh.com.au
May 14, 2008
Sydney Morning Herald, Australia -
A map of your genetic destiny and tailor-made medications are closer, and cheaper, than you think, writes Steve Dow. A new genetic era is dawning, and this time medicine is getting personal. Cancer, stroke, heart disease, osteoporosis - in the next few years a ...
KNDO/KNDU Tri-Cities, Yakima, WA | AIDS and HIV Infection
Jun 26, 2007
KNDO/KNDU, WA -
EFV) Bristol-Myers Squibb Nevirapine (Viramune, NVP) Boehringer Ingelheim Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Abacavir (Ziagen, ...
Aidsmap | A short course of potent HIV therapy during primary infection may slow longer-term disease progression
Jun 26, 2007
Aidsmap, UK -
Those who took efavirenz also received abacavir (Ziagen). One person was excluded due to incomplete data; the remaining 89 of this SCART group were analysed .For comparison, 179 controls were selected from the 8,908 participants in the European CASCADE collaboration cohort. Controls were matched for ...
Abacavir Sulfate and Mania in HIV -- BROUILETTE and ROUTY 164 (6): 979 -- Am J Psychiatry
May 31, 2007
Am J Psychiatry (subscription) -
We describe the case of a patient with mania that was associated with abacavir sulfate, another non-nucleoside reverse transcriptase inhibitor. The patient was a 47-year-old man infected with human immunodeficiency virus (HIV) for 9 years prior to a manic ...
Aidsmap | Abacavir hypersensitivity screen as part of drug resistance test possible
Sunday, June 03, 2007
Aidsmap, UK -
to HLA typing as a way of predicting who will develop hypersensitivity to the nucleoside analogue abacavir (Ziagen), say Canadian researchers. One of the biggest potential benefits is that the technique - called the RT codon 245 test - could ...
ImediNews - FDA warns of HIV drug mix-up
Apr 12, 2007
ImediNews, Georgia -
WASHINGTON, April 12 (UPI) — The US Food and Drug Administration said Thursday that bottles of HIV drug Ziagen may have been mislabeled as Combivir, another HIV drug.The FDA and GlaxoSmithKline, which makes both drugs, said it appears the bottles were tampered with by ...
Drug Access | FDA Grants Tentative Approval for Matrix's Antiretroviral Drug Abacavir - Kaisernetwork.org
Apr 12, 2007
Kaiser network.org, DC -
Abacavir is the generic version of GlaxoSmithKline's Ziagen ( Kaiser Daily HIV/AIDS Report , 5/25/06). The tentative approval designation means the drug meets FDA safety and efficacy standards but cannot be sold in the U.S. because of existing patents or exclusivity ...
FDA Alerts Pharmacists About Mislabeling of HIV Drugs - CME Teaching Brief® - MedPage Today
Apr 11, 2007
MedPage Today, NJ -
A letter sent to pharmacists said the incidents, which involved abacavir sulfate (Ziagen) and a combination of lamvudine and zidovudine (Combivir), ...
Facts & Comparisons: Isolated Case of Counterfeit Combivir on the Market
Apr 12, 2007
Facts and Comparisons, MO -
GlaxoSmithKline is informing health care professionals of an incident of misbranding of Ziagen (abacavir sulfate) as Combivir (lamivudine/zidovudine). Apparently, counterfeit Combivir labels were used by a third party. Two 60-count misbranded bottles of Combivir tablets (lot ...
Health: FDA Warns Of HIV Drug Mix-Up - The Post Chronicle
Apr 12, 2007
Post Chronicle -
The US Food and Drug Administration said Thursday that bottles of HIV drug Ziagen may have been mislabeled as Combivir, another HIV drug. The FDA and GlaxoSmithKline, which makes both drugs, said it appears the bottles were tampered with by a third party ...
FDA Warns of HIV Drug Tampering
Apr 11, 2007
WebMD -
April 11, 2007 -- The FDA today warned that certain bottles of the HIV drug Combivir may actually contain Ziagen, another HIV drug. Certain Ziagen bottles were apparently tampered with by a third party andmisbranded as Combivir with counterfeit ...
FDA Warns Of HIV Drug Tampering, Combivir Bottles May Contain Ziagen, Another HIV Drug - CBS News
Apr 11, 2007
CBS News, NY -
(WebMD) The FDA today warned that certain bottles of the HIV drug Combivir may actually contain Ziagen, another HIV drug. Certain Ziagen bottles were apparently tampered with by a third party and misbranded as Combivir with counterfeit labels, say the FDA and GlaxoSmithKline, ...
PharmaLive: FDA Announces Important Notice About Combivir and Ziagen
Apr 10, 2007
PharmaLive.com (press release), PA -
We would like to call to your attention an apparent third-party tampering that caused misbranding of Ziagen® (abacavir sulfate) Tablets as Combivir® ...
PharmaLive: FDA Announces Tentative Approval of Generic Abacavir Sulfate Tablets
Apr 6, 2007
PharmaLive.com (press release), PA -
Abacavir sulfate is a member of the class of drugs known as nucleoside reverse transcriptase inhibitors (NRTIs), which help keep the AIDS virus from reproducing. This antiretroviral drug is intended to be used in combination with other antiretroviral agents for the treatment of ...
Polish Market - GSK to export to 70 markets from Poznan
Mar 1, 2007
Polish Market, Poland -
The factory has also became the packaging plant for four innovative anti-retroviral drugs used in HIV/AIDS therapy (Combivir, Epivir, Trizivir and Ziagen) and one used in chronic hepatitis B (Zeffix). Delivery of two of these products to Western and Central Europe ...
Pharmaceutical Processing
Feb 21, 2007
Pharmaceutical Processing, NJ -
The initial two drugs included in the International Standards program are used in the treatment of HIV-AIDS: Abacavir Sulfate, and Efavirenz. These monographs are posted in draft form, with a 90-day period for public comment that ends on April 30, ...
USP Publishes Standards For Medications For Neglected Diseases
Tuesday, January 30, 2007
Medical News Today (press release), UK -
The United States Pharmacopeia (USP) has released free documentary standards for medicines used outside the United States to treat neglected infectious diseases. The standards are available on USP's Web site at http://www.usp.org/internationalStandards. "Public standards for such medicines are urgently needed ...
USP Publishes Standards for Medications for Neglected Diseases
Jan 29, 2007
PR Newswire (press release), NY -
- International Standards Monographs Provided Free to Help Ensure Good Quality Medicines for Underserved Populations - ROCKVILLE, Md., Jan. 29 /PRNewswire/ -- The United States Pharmacopeia(USP) has released free documentary standards for medicines used outsidethe United States to ...
Public standards for world medications to treat neglected infectious diseases
Jan 29, 2007
News-Medical.net, Australia -
"Public standards for such medicines are urgently needed to help ensure that patients in all parts of the world have access to good quality medications," ...
Looking for a District of Columbia Ziagen lawyer? Get in touch with one of our District of Columbia Ziagen lawyers now.

AddThis Social Bookmark Button

 

Need A Ziagen Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Ziagen Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Ziagen Case - Submit Your Information Below

Do you need legal assistance with your Ziagen case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Ziagen Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.